MESI ABPI MD (ankle brachial index)

Why Measure for ABI (Ankle Brachial Index)?

The Ankle Brachial Index (ABI) is a crucial diagnostic tool for identifying Peripheral Arterial Disease (PAD), a condition where narrowed arteries reduce blood flow to the limbs. With an estimated 236 million adults affected by PAD worldwide, ABI plays an essential role in early detection and prevention of complications. It is particularly valuable for screening patients at risk of cardiovascular disease, which accounts for 35% of global deaths.

Why Is ABI Screening So Important?

70% of PAD Patients Have No Symptoms: Many cases go undiagnosed without proper screening.
One-Third of Asymptomatic Patients Have Masked LEAD: Lower Extremity Arterial Disease can remain hidden, making early detection critical.
13% of the Population Is Affected by PAD: Highlighting the widespread need for screening and early intervention.

Measuring ABI is a simple yet effective way to identify PAD and protect overall cardiovascular health.

What is Peripheral Arterial Disease (PAD)?

Peripheral Arterial Disease (PAD) is a life-threatening circulatory condition caused by narrowed arteries, which reduce blood flow to the limbs. Despite its severity, PAD is often underdiagnosed and undertreated, leading to significant complications.

How can I best measure ABI?

The MESI ABPI MD is the world’s fastest screening tool for measuring ABI. It takes 1-minute to discover blocked arteries.

4CUFF™ Technology for Safe and Efficient Measurement

The 4CUFF™ technology ensures a reliable and accurate measurement process by utilizing advanced features designed for safety and efficiency:

Simultaneous Inflation and Deflation: All cuffs inflate and deflate at the exact same time, capturing the exact same heartbeat for precise readings.
Risk-Free Design: By compressing both arms and legs with four or more cuffs, the technology avoids cardiac overload, ensuring patient safety during measurements.
Eliminates Errors: No blood pressure drift and no room for human error, guaranteeing accurate and consistent results every time.

4CUFF™ sets a new standard for safe, efficient, and accurate vascular assessments.

Why Choose MESI?

In today’s fast-paced healthcare environment, having a simple and reliable diagnostic tool is essential for determining the appropriate level of compression therapy for patients.

The MESI ABPI MD offers:

Ease of Use: Minimal training is required, allowing clinicians to quickly incorporate it into their practice.
Efficient Screening: Screen every patient for Peripheral Arterial Disease (PAD) with ease, ensuring early detection and appropriate care.
Tailored Compression Therapy: Once PAD is assessed, confidently move forward with a compression therapy program best suited to each patient’s needs.

Choose MESI for streamlined diagnostics and improved patient outcomes.